TICKERNERD
Menu
MMSMMSIndustrials · Specialty Business Services

MMS Stock Forecast: MAXIMUS, Inc. Price Predictions for 2026-2027

Last close, 14 Aug 2026
$55
−1.39% on the day

The 2 Wall Street analysts covering MAXIMUS, Inc. hold a median 12-month price target of $93 — +67.3% from the last close. Ticker Nerd's systematic factor model, run across ~4,600 US stocks, ranks it 79 of 100 as at 15 Aug 2026 — inside the top quartile. Here, the model and the Street point the same way.

Market cap
$2.9B
Ticker Nerd rank
79 / 100
Median analyst target
$93
Analysts covering
2
Total return, dividends reinvested
1W
−6.6%
1M
−4.0%
YTD
−35.3%
1Y
−33.4%
From 52W high
−43.6%
From 52W low
+2.8%
$54
$98
52-week range, adjusted closes · the dot is the last close
Ticker Nerd rank

MMS stock analysis: one number for the whole business

Consensus tells you what everyone already believes. The model scores MAXIMUS, Inc. on its factor families — the same systematic rank behind the Ticker Nerd portfolio.

Where the model ranks itAs at 15 Aug 2026
79 / 100

Percentile across ~4,600 US stocks on Ticker Nerd’s systematic factor model. Higher is better. How the model is built and tested

Value
97
Issuance
96
Quality
89
Volatility
89
Accruals
68
Growth
60
Revisions
33
Size
31
Momentum
29

Value (97): The shares cost little relative to the profits and assets behind them — which can mean the market is too gloomy, or that the business really is in trouble.

Momentum (29): The shares have been drifting down relative to others.

Built and run by Aslam Ghouse, an ex-Goldman Sachs quant trader with fourteen years in markets.

Wall Street

MMS stock forecast 2026-2027: analyst price targets & predictions

The bullish and bearish analyst opinions on MMS, reported as data — targets and ratings, the market's view beside the model's.

Share price and the analyst range, 12 monthsAdjusted close, US dollars
$50$60$70$80$90$100$110Oct 25Jan 26Apr 26Jul 26MMSHigh $110Median $93Low $75

Price targets and ratings are third-party analyst estimates, reported here as data. They are not Ticker Nerd forecasts, and they are frequently wrong.

What Wall Street says2 analysts
2 Buy0 Hold0 Sell
Low $75Median $93High $110

The green dot is the last close — the median target sits +67.3% from it.

Recent analyst actionsNewest first
DateFirmActionRatingTarget
2 Jan 2025Raymond JamesUpgradeOutperform$90
3 Jan 2024Raymond JamesDowngradeMarket Perform—
18 Aug 2023StifelInitiatesBuy—
9 Feb 2023Raymond JamesMaintainsOutperform—
6 May 2022Raymond JamesMaintainsOutperform—
28 June 2021Raymond JamesDowngradeOutperform—
7 May 2021Raymond JamesMaintainsStrong Buy—
22 Apr 2021Canaccord GenuityMaintainsHold—
5 Feb 2021Raymond JamesMaintainsStrong Buy—
7 Aug 2020KeybancMaintainsOverweight—
7 Aug 2020KeyBancMaintainsOverweight—
8 July 2020Raymond JamesUpgradeStrong Buy—
24 June 2020KeybancUpgradeOverweight—
24 June 2020KeyBancUpgradeOverweight—
8 Jan 2020Wells FargoMaintainsEqual-Weight—
13 Aug 2019Canaccord GenuityMaintainsHold—
9 Aug 2019Wells FargoDowngradeMarket Perform—
10 Oct 2018Canaccord GenuityMaintainsHold—
11 May 2018Canaccord GenuityMaintainsHold—
8 May 2018First AnalysisUpgradeOverweight—

Price targets and ratings are third-party analyst estimates, reported here as data. They are not Ticker Nerd forecasts, and they are frequently wrong.

Market Radar

This page is one stock. Monday covers all of them.

Computed off the Friday close and sent before the US open.

Market Radar reports the week’s largest rank changes across roughly 4,600 US stocks, the factor behind each one, and where the market went. MMS appears on the weeks it earns a place.

Free, every Monday. Unsubscribe any time.

Estimates

MMS analyst estimate revisions

Not the forecast itself — the direction analysts are revising it. Revision direction is one of the model's factor families.

Which way the estimates are movingNext fiscal year
EPS revision, 90 days
−2.9%
Analysts raising
1
Analysts cutting
1
Fundamentals

MAXIMUS, Inc. (MMS) financial data

A margin means little on its own. Each bar marks where the figure sits across the whole US universe we score.

Valuation
Trailing P/E
8.2×

Cheaper than 62% of US stocks

Price / sales
0.6×

Cheaper than 81% of US stocks

Price / book
1.7×

Cheaper than 53% of US stocks

EV / EBITDA
6.6×

Cheaper than 50% of US stocks

Growth & margins
Revenue growth (YoY)
−5.1%

Higher than 20% of US stocks

Earnings growth (YoY)
−2.3%

Higher than 33% of US stocks

Gross margin
27.3%

Higher than 31% of US stocks

Operating margin
12.6%

Higher than 68% of US stocks

Net margin
7.1%

Higher than 65% of US stocks

Returns & dividend
Return on equity
21.1%

Higher than 82% of US stocks

Return on assets
8.2%

Higher than 88% of US stocks

Dividend yield
2.4%

Higher than 54% of US dividend payers

Bars mark the percentile across the ~4,600 US stocks Ticker Nerd covers, among those reporting the figure.

Peers

MMS vs competitors

The nearest names by industry and size, scored by the same model — like for like.

Its peer group, ranked by the same modelSpecialty Business Services
CompanyMarket capTKN rank
MMSMAXIMUS, Inc.$2.9B
79
CBZCBIZ, Inc.$3.0B
64
ABMABM Industries, Inc.$2.9B
86
FAFirst Advantage Corp.$3.8B
92
CMPRCimpress PLC$2.3B
92
TICTIC Solutions, Inc.$2.2B
5
AZZAZZ, Inc.$4.5B
87

Look up any of the roughly 4,600 stocks we score.

The rank is the raw material. Whether the rules would actually own MAXIMUS, Inc. — and when they’d sell — is the membership. See the Ticker Nerd 20 →

News

Latest MMS news & analysis

Can Maximus Weather the VA Contract Hit and Rebuild Earnings Momentum?

Zacks Investment Research · 12 Aug 2026negative

Maximus faces an earnings reset as paused VA incentives reduce its profit and cash-flow guidance. The company's ability to rebuild earnings momentum now rests on gains in its service and technology operations.

Why it matters — A Maximus watcher would care because the paused VA incentives have directly cut the company's profit and cash-flow guidance, placing its near-term earnings trajectory in question.

Is Maximus Stock Worth Buying as Low Valuation Meets Contract Risk?

Zacks Investment Research · 12 Aug 2026negative

A Zacks Investment Research item notes that Maximus stock trades at a deep earnings discount, but federal procurement delays and weak award conversion cloud the timing of a recovery. The piece weighs the low valuation against the contract-related risks affecting the company's outlook.

Why it matters — MMS watchers would care because federal procurement delays and weak award conversion directly influence the timing and pace of the company's potential earnings recovery.

Maximus Q3 Earnings Call Highlights

MarketBeat · 8 Aug 2026positive

Maximus reported fiscal 2026 third-quarter revenue of $1.28 billion, in line with expectations. Adjusted EBITDA margin improved to 15.0% from 14.7% a year earlier, and adjusted diluted EPS rose to $2.22 from $2.16.

Why it matters — The quarter shows improving profitability, with higher adjusted EBITDA margin and earnings per share versus the prior-year period.

Maximus Q3 Earnings Beat Estimates, Increase Year Over Year

Zacks Investment Research · 7 Aug 2026neutral

Maximus reported fiscal Q3 earnings that beat analyst estimates and increased year over year, though the company missed on revenue expectations. Higher margins offset softer sales, while the firm reduced its fiscal 2026 profit guidance.

Why it matters — A MMS watcher would care because the earnings beat and margin improvement contrast with softer revenue and a cut to 2026 profit guidance, signaling mixed near-term fundamentals.

Maximus, Inc. (MMS) Q3 2026 Earnings Call Transcript

Seeking Alpha · 7 Aug 2026neutral

Maximus, Inc. held its Q3 2026 earnings call, during which management discussed the company's financial results and operations for the quarter. The transcript of that call was published on Seeking Alpha.

Why it matters — The earnings call transcript provides investors and analysts with direct insight into management's perspective on Maximus's recent performance and outlook.

FAQ

Frequently asked questions about MMS stock

What is the MMS stock price forecast for 2026-2027?

The 2 Wall Street analysts covering MAXIMUS, Inc. have a median 12-month price target of $93, with estimates ranging from $75 to $110. These are third-party analyst estimates, not Ticker Nerd forecasts, and they are frequently wrong.

Is MMS stock a buy right now?

Of the 2 analysts covering MAXIMUS, Inc., 2 rate it a Buy, 0 a Hold and 0 a Sell. Ticker Nerd's systematic factor model ranks MAXIMUS, Inc. 79 out of 100 across roughly 4,600 US stocks as at 15 Aug 2026. None of this is personal advice — it does not consider your circumstances.

How does Ticker Nerd's model rank MMS?

As at 15 Aug 2026, MAXIMUS, Inc. ranks 79 out of 100 on Ticker Nerd's systematic factor model — a percentile across roughly 4,600 US stocks, built from its factor families. Its strongest factor family is Value (97 of 100).

Will MMS stock go up?

No one can know that. What the data says: the median 12-month target from 2 analysts implies +67.3% from the last close, and Ticker Nerd's factor model ranks MAXIMUS, Inc. 79 out of 100 as at 15 Aug 2026. Analyst targets are third-party estimates and frequently wrong; none of this is personal advice.

What is the MMS stock forecast for 2030?

No analyst covering MAXIMUS, Inc. publishes a 2030 price target — Wall Street targets run 12 to 18 months out. Sites quoting a 2030 price for MMS are extrapolating price history, which says nothing about the business. The furthest attributed numbers are the current analyst targets: $75 to $110 over the next 12 months.

How has MMS stock performed over the past year?

MAXIMUS, Inc. returned -33.4% over the 12 months to 14 Aug 2026, with dividends reinvested. Past performance does not indicate future returns.

What does MAXIMUS, Inc. do?

Maximus Inc. operates as a leading provider of health and human services worldwide.

What is the latest news on MMS?

The most recent item we track (Zacks Investment Research, 12 Aug 2026): "Can Maximus Weather the VA Contract Hit and Rebuild Earnings Momentum?". Maximus faces an earnings reset as paused VA incentives reduce its profit and cash-flow guidance. The company's ability to rebuild earnings momentum now rests on gains in its service and technology operations.

Company

About MAXIMUS, Inc.

Maximus Inc. operates as a leading provider of health and human services worldwide. Its primary function is to offer business process services to government programs, focusing on delivering comprehensive administrative solutions and consultancy services that enhance public service delivery. Notably, Maximus serves healthcare, welfare, and employment industries, assisting governments in implementing and improving initiatives such as Medicaid and Medicare in the United States, as well as other international service programs. By managing complex processes and technology infrastructure, Maximus aids in optimizing efficiency and effectiveness for public sector clients. Headquartered in Reston, Virginia, Maximus Inc. holds a significant role in the market by bridging government operations with practical, efficiency-driven solutions. The company's influence extends globally as it partners with various governments to support program administration and ensure compliance with regulatory standards. Maximus is instrumental in facilitating citizen engagement and improving access to essential services, underscoring its importance in contributing to public health and economic resilience. By streamlining operations through technological and strategic expertise, Maximus continues to impact the delivery of critical social services across the world.

CEO Mr. Bruce L. Caswell · 37,200 employees · United States · https://www.maximus.com